Fabian, Alexander http://orcid.org/0000-0003-2415-527X
Rühle, Alexander
Domschikowski, Justus
Trommer, Maike
Wegen, Simone
Becker, Jan-Niklas
Wurschi, Georg
Boeke, Simon
Sonnhoff, Mathias
Fink, Christoph A.
Käsmann, Lukas
Schneider, Melanie
Bockelmann, Elodie
Treppner, Martin
Mehnert-Theuerkauf, Anja
Nicolay, Nils H.
Krug, David
,
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Article History
Received: 13 August 2023
Accepted: 22 October 2023
First Online: 17 November 2023
Declarations
:
: A. Rühle received speaker honoraria from Merck KgaA and research funding, consulting fees and reimbursements for travel expenses from Novocure GmbH. D. Krug received honoraria from Merck Sharp & Dohme and Pfizer, medupdate, onkowissen, best practice onkologie, ESO, ESMO and Gilead as well as research funding from Merck KGaA, outside of the submitted work. G. Wurschi received funding by the “Clinician Scientist”-program of the Interdisciplinary Center for Clinical Research, Jena University Hospital (grant-No.: CSP-11). L. Käsmann received honoraria from AMGEN outside of the mentioned study. N.H. Nicolay received speaker honoraria from Merck KgaA and research funding from Novocure GmbH. A. Fabian, J. Domschikowski, M. Trommer, S. Wegen, J.-N. Becker, S. Boeke, M. Sonnhoff, C.A. Fink, M. Schneider, E. Bockelmann, M. Treppner and A. Mehnert-Theuerkauf declare that they have no competing interests.
: <i>Ethics approval: </i>This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the respective Ethics Committee of each participating center. <i>Consent to participate: </i>Informed consent was obtained from all individual participants included in the study.